Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 3, 2013, Pages

  Luk, N M ^a   Chiu, L S ^b   Lee, K C ^c   Chau, C T S ^a   Lee, V W Y ^a   Chang, M ^d   Lam, Y K ^e   Lee, H C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Private Practice   (Hong Kong)

^c MONASH UNIVERSITY MALAYSIA   (Malaysia)

^d and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^e DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENCYPRONE; FLUKA; STEROID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALOPECIA AREATA; ARTICLE; ATOPY; BLISTER; CERVICAL LYMPHADENOPATHY; CHILD; CHINESE; CLINICAL ARTICLE; CONTACT URTICARIA; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECZEMA; ERYTHEMA; FAMILY HISTORY; FEMALE; FOLLOW UP; HAIR GROWTH; HUMAN; HYPERPIGMENTATION; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; NAIL DISEASE; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SCHOOL CHILD; SIDE EFFECT; SKIN MANIFESTATION; SKIN PRURITUS; SKIN SCALING; THYROID DISEASE; TREATMENT REFUSAL; TREATMENT RESPONSE; VITILIGO;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ALOPECIA AREATA; CHILD; CHINA; CYCLOPROPANES; FEMALE; HUMANS; MALE; PROGNOSIS; YOUNG ADULT;

EID: 84874106483     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12009     Document Type: Article

References (29)

1. King LE Jr, McElwee KJ, Sundberg JP,. Alopecia areata. Curr Dir Autoimmun 2008; 10: 280-312.
2. Willemsen R, Vanderlinden J, Roseeuw D, Haentjens P,. Increased history of childhood and lifetime traumatic events among adults with alopecia areata. J Am Acad Dermatol 2009; 60: 388-393.
3. Barahmani N, Schabath MB, Duvic M,. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol 2009; 61: 581-591.
4. Alkhalifah A, et al. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010; 62: 177-88, quiz 189-190.
5. Gregoriou S, et al. Cytokines and other mediators in alopecia areata. Mediators Inflamm 2010; 2010: 928030.
6. Kang H, et al. Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss. J Invest Dermatol 2010; 130: 2677-2680.
7. Alkhalifah A, et al. Alopecia areata update: part II. Treatment. J Am Acad Dermatol 2010; 62: 191-202, quiz 203-204.
8. Ito T, et al. Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata. Arch Dermatol Res 2009; 301: 373-80.
9. Rallis E, et al. Oral administration of cyclosporin A in patients with severe alopecia areata. Int J Tissue React 2005; 27: 107-110.
10. Smith JR, Akin RS, Wells MJ,. Alopecia areata treated with efalizumab: a case with significant hair re-growth after long-term therapy. J Drugs Dermatol 2009; 8: 758-760.
11. Strober BE, et al. Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study. J Am Acad Dermatol 2005; 52: 1082-1084.
12. Singh G, Lavanya M,. Topical immunotherapy in alopecia areata. Int J Trichology 2010; 2: 36-39.
13. Cotellessa C, et al. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. J Am Acad Dermatol 2001; 44: 73-76.
14. Avgerinou G, et al. Alopecia areata: topical immunotherapy treatment with diphencyprone. J Eur Acad Dermatol Venereol 2008; 22: 320-323.
15. Sotiriadis D, et al. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata. Clin Exp Dermatol 2007; 32: 48-51.
16. Aghaei S,. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population. BMC Dermatol 2005; 5: 6.
17. van der Steen PH, et al. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 1991; 24 (2 Pt 1): 227-230.
18. van der Steen PH, et al. Treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 1991; 24 (2 Pt 1): 253-257.
19. Galadari I, et al. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA). Eur Ann Allergy Clin Immunol 2003; 35: 397-401.
20. Francomano M, Seidenari S,. Urticaria after topical immunotherapy with diphenylcyclopropenone. Contact Derm 2002; 47: 310-311.
21. Ganzetti G, et al. Phototherapy as a useful therapeutic option in the treatment of diphenylcyclopropenone-induced vitiligo. Acta Derm Venereol 2010; 90: 642-643.
22. Inui S, et al. Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata. J Dermatol 2010; 37: 888-893.
23. Perret CM, et al. Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone. Dermatologica 1990; 180: 5-7.
24. Daman LA, Rosenberg EW, Drake L,. Treatment of alopecia areata with dinitrochlorobenzene. Arch Dermatol 1978; 114: 1036-1038.
25. Wiseman MC, et al. Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol 2001; 137: 1063-1068.
26. Ohlmeier MC, et al. Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata-a large retrospective study on 142 patients with a self-controlled design. J Eur Acad Dermatol Venereol 2012; 26: 503-507.
27. Olsen EA, et al. Alopecia areata investigational assessment guidelines - Part II. National Alopecia Areata Foundation. J Am Acad Dermatol 2004; 51: 440-447.
28. Tosti A, Bellavista S, Iorizzo M,. Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol 2006; 55: 438-441.
29. El-Zawahry BM, et al. Five-year experience in the treatment of alopecia areata with DPC. J Eur Acad Dermatol Venereol 2010; 24: 264-269.